Skip to main content
Literatur
1.
Zurück zum Zitat WHO. WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020. March 11 hwwidsd WHO. WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020. March 11 hwwidsd
2.
Zurück zum Zitat Fang L, Karakiulakis G, Roth M (2020) Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med 8:e21CrossRef Fang L, Karakiulakis G, Roth M (2020) Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med 8:e21CrossRef
3.
Zurück zum Zitat Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395(10223):497–506CrossRef Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395(10223):497–506CrossRef
4.
Zurück zum Zitat Favalli EG, Ingegnoli F, De Lucia O, Cincinelli G, Cimaz R, Caporali R (2020) COVID-19 infection and rheumatoid arthritis: faraway, so close! Autoimmun Rev 19(5):102523 Favalli EG, Ingegnoli F, De Lucia O, Cincinelli G, Cimaz R, Caporali R (2020) COVID-19 infection and rheumatoid arthritis: faraway, so close! Autoimmun Rev 19(5):102523
5.
Zurück zum Zitat Yang X, Yu Y, Xu J, Shu H, Liu H, Wu Y et al (2020) Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 8(5):475–481 Yang X, Yu Y, Xu J, Shu H, Liu H, Wu Y et al (2020) Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 8(5):475–481
6.
Zurück zum Zitat Giovannoni G, Hawkes C, Lechner-Scott J, Levy M, Waubant E, Gold J (2020) The COVID-19 pandemic and the use of MS disease-modifying therapies. Mult Scler Relat Disord 39:102073 Giovannoni G, Hawkes C, Lechner-Scott J, Levy M, Waubant E, Gold J (2020) The COVID-19 pandemic and the use of MS disease-modifying therapies. Mult Scler Relat Disord 39:102073
7.
Zurück zum Zitat Totura AL, Baric RS (2012) SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon. Curr Opin Virol 2(3):264–275CrossRef Totura AL, Baric RS (2012) SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon. Curr Opin Virol 2(3):264–275CrossRef
8.
Zurück zum Zitat Moreno Torres I, Garcia-Merino A (2017) Anti-CD20 monoclonal antibodies in multiple sclerosis. Expert Rev Neurother 17(4):359–371CrossRef Moreno Torres I, Garcia-Merino A (2017) Anti-CD20 monoclonal antibodies in multiple sclerosis. Expert Rev Neurother 17(4):359–371CrossRef
9.
Zurück zum Zitat Chen C, Shi L, Li Y, Wang X, Yang S (2016) Disease-specific dynamic biomarkers selected by integrating inflammatory mediators with clinical informatics in ARDS patients with severe pneumonia. Cell Biol Toxicol 32(3):169–184CrossRef Chen C, Shi L, Li Y, Wang X, Yang S (2016) Disease-specific dynamic biomarkers selected by integrating inflammatory mediators with clinical informatics in ARDS patients with severe pneumonia. Cell Biol Toxicol 32(3):169–184CrossRef
10.
Zurück zum Zitat Percopo CM, Ma M, Brenner TA, Krumholz JO, Break TJ, Laky K, Rosenberg HF (2019) Critical adverse impact of IL-6 in acute pneumovirus infection. J Immunol 202(3):871–882CrossRef Percopo CM, Ma M, Brenner TA, Krumholz JO, Break TJ, Laky K, Rosenberg HF (2019) Critical adverse impact of IL-6 in acute pneumovirus infection. J Immunol 202(3):871–882CrossRef
11.
Zurück zum Zitat Berry DJ, Hesketh K, Power C, Hyppönen E (2011) Vitamin D status has a linear association with seasonal infections and lung function in British adults. Br J Nutr 106(9):1433–1440CrossRef Berry DJ, Hesketh K, Power C, Hyppönen E (2011) Vitamin D status has a linear association with seasonal infections and lung function in British adults. Br J Nutr 106(9):1433–1440CrossRef
12.
Zurück zum Zitat Cannell J, Vieth R, Umhau J, Holick M, Grant W, Madronich S et al (2006) Epidemic influenza and vitamin D. Epidemiol Infect 134(6):1129–1140CrossRef Cannell J, Vieth R, Umhau J, Holick M, Grant W, Madronich S et al (2006) Epidemic influenza and vitamin D. Epidemiol Infect 134(6):1129–1140CrossRef
13.
Zurück zum Zitat Khare D, Godbole NM, Pawar SD, Mohan V, Pandey G, Gupta S, Kumar D, Dhole TN, Godbole MM (2013) Calcitriol [1, 25 [OH] 2 D3] pre-and post-treatment suppresses inflammatory response to influenza A (H1N1) infection in human lung A549 epithelial cells. Eur J Nutr 52(4):1405–1415CrossRef Khare D, Godbole NM, Pawar SD, Mohan V, Pandey G, Gupta S, Kumar D, Dhole TN, Godbole MM (2013) Calcitriol [1, 25 [OH] 2 D3] pre-and post-treatment suppresses inflammatory response to influenza A (H1N1) infection in human lung A549 epithelial cells. Eur J Nutr 52(4):1405–1415CrossRef
14.
Zurück zum Zitat Bergman P, Lindh ÅU, Björkhem-Bergman L, Lindh JD (2013) Vitamin D and respiratory tract infections: a systematic review and meta-analysis of randomized controlled trials. PLoS One 8(6):e65835CrossRef Bergman P, Lindh ÅU, Björkhem-Bergman L, Lindh JD (2013) Vitamin D and respiratory tract infections: a systematic review and meta-analysis of randomized controlled trials. PLoS One 8(6):e65835CrossRef
15.
Zurück zum Zitat Laursen JH, Søndergaard HB, Sørensen PS, Sellebjerg F, Oturai AB (2016) Vitamin D supplementation reduces relapse rate in relapsing-remitting multiple sclerosis patients treated with natalizumab. Mult Scler Relat Disord 10:169–173CrossRef Laursen JH, Søndergaard HB, Sørensen PS, Sellebjerg F, Oturai AB (2016) Vitamin D supplementation reduces relapse rate in relapsing-remitting multiple sclerosis patients treated with natalizumab. Mult Scler Relat Disord 10:169–173CrossRef
16.
Zurück zum Zitat Faridar A, Eskandari G, Sahraian MA, Minagar A, Azimi A (2012) Vitamin D and multiple sclerosis: a critical review and recommendations on treatment. Acta Neurol Belg 112(4):327–333CrossRef Faridar A, Eskandari G, Sahraian MA, Minagar A, Azimi A (2012) Vitamin D and multiple sclerosis: a critical review and recommendations on treatment. Acta Neurol Belg 112(4):327–333CrossRef
Metadaten
Titel
Are patients with multiple sclerosis (MS) at higher risk of COVID-19 infection?
verfasst von
Mahsa Ghajarzadeh
Simona Bonavita
Publikationsdatum
07.07.2020
Verlag
Springer International Publishing
Schlagwort
COVID-19
Erschienen in
Neurological Sciences / Ausgabe 9/2020
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-020-04570-8

Weitere Artikel der Ausgabe 9/2020

Neurological Sciences 9/2020 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Neu im Fachgebiet Neurologie

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.